UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059510
Receipt number R000068073
Scientific Title Characteristics of Physical Activity According to Activities of Daily Living in Cancer Survivors Attending a Palliative Care Center: A Preliminary Study
Date of disclosure of the study information 2025/10/23
Last modified on 2025/10/23 10:43:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics of Physical Activity According to Activities of Daily Living in Cancer Survivors Attending a Palliative Care Center: A Preliminary Study

Acronym

PA-ADL in Cancer (Pilot)

Scientific Title

Characteristics of Physical Activity According to Activities of Daily Living in Cancer Survivors Attending a Palliative Care Center: A Preliminary Study

Scientific Title:Acronym

OncoPADL-Pilot

Region

Japan


Condition

Condition

Cancer Survivors Attending a Palliative Care Center

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To characterize, by Performance Status level, physical activity measures sedentary time, light intensity activity time, moderate to vigorous activity time, and prolonged sedentary bout indices.

Basic objectives2

Others

Basic objectives -Others

To estimate associations between physical activity indicators and physical symptoms.
To determine planning parameters for the definitive trial population standard deviations of physical activity indicators, minimum required measurement days, device wearing adherence, and missing-data rates.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sedentary time per day (1.5 METs or lower, min/day)
Light intensity physical activity time per day (1.6 to 2.9 METs, min/day)
Moderate to vigorous physical activity time per day (3 METs or more, min/day)

Key secondary outcomes

Frequency and duration per day of 30- and 60-minute sedentary bouts
Associations with ESAS-r-J item and total scores (correlations; exploratory regression)
Minimum measurement days: k satisfying ICC(1,k) 0.70 or more
Wear adherence: proportion of days with valid wear time 10 h/day or more
Missing-data rates (within-person and overall)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult cancer outpatients attending the Palliative Care Clinic, Department of Supportive Care, Saitama Medical University International Medical Center
Age 18 years or more

Key exclusion criteria

Deemed by the physician unable to participate or complete the questionnaire
Performance Status 3 or more

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Natsuki
Middle name
Last name Shimizu

Organization

Saitama Medical University

Division name

Department of Physical Therapy, Faculty of Health and Medical Care

Zip code

350-0496

Address

981, Kawakado, Mroyama, Saitama

TEL

0492951001

Email

natsuki@saitama-med.ac.jp


Public contact

Name of contact person

1st name Natsuki
Middle name
Last name Shimizu

Organization

Saitama Medical University

Division name

Department of Physical Therapy, Faculty of Health and Medical Care

Zip code

350-0496

Address

981, Kawakado, Mroyama, Saitama

TEL

09099701144

Homepage URL


Email

natsuki@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

FY2025 Faculty of Health and Medical Care Project Research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Center for Promotion of Proper Clinical Research, Saitama Medical University International Medical Center

Address

1397-1 Yamane, Hidaka, Saitama, Japan

Tel

0429844523

Email

chikens@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学国際医療センター


Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 30 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Preliminary


Management information

Registered date

2025 Year 10 Month 23 Day

Last modified on

2025 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068073